What happened in the premarket for Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock?
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), shares nosedived in the premarket session today as it recorded down -33.49% to reach $61.47. There is no clear answer to why this stock dropped todayother than “confused investors.” Get the hottest stocks to trade every day before the market opens 100% free. Click here now. The only […]
Barclays lowers Arcturus Therapeutics Holdings Inc (ARCT) rating to Equal Weight and sets price target at $46
Barclays took its Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) rating to the equivalent of Equal Weight from Overweight, and the price target to $46, in a research note dated December 29, 2020. Other analysts also revised their coverage, with ROTH Capital’s analysts downgrading the shares from ”a Buy” rating to “a Sell” rating in a […]
